METHOD AND APPARATUS FOR HEAT OR ELECTROMAGNETIC CONTROL OF GENE EXPRESSION

• US 20070190028A1
• Filed: 02/13/2006
• Published: 08/16/2007
• Est. Priority Date: 02/13/2006
• Status: Abandoned Application

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Qu, Jihong, Stolen, Craig
• Application Number:
  US11/276,077
• Publication Number:
  US 20070190028A1
• Time in Patent Office: Days
• US Class Current: 424/93.2
• CPC Class Codes: A61K 48/0058 Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
• CPC Class Codes: A61N 1/326 for promoting growth of cells, e.g. bone cells
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: A61N 1/3629 in combination with non-electric therapy
• CPC Class Codes: A61N 1/36514 controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by two or more physical parameters A61N1/36585
• CPC Class Codes: A61P 17/02 for treating wounds, ulcers, burns, scars, keloids, or the like
• CPC Class Codes: A61P 19/00 Drugs for skeletal disorders
• CPC Class Codes: A61P 25/00 Drugs for disorders of the nervous system
• CPC Class Codes: A61P 9/10 for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

A gene regulatory system controls biomarker, gene therapy or endogenous gene expression by emitting one or more forms of energy that regulate gene expression. The system may include a sensor to sense a signal indicative of a need for therapy. The regulation of gene expression is controlled based on the sensed signal and/or a user command. In one embodiment, the system delivers one or more electrical therapies in conjunction with controlling gene therapy or endogenous gene expression.

Claims

1. A system, comprising;

a gene regulatory signal delivery device that emits a regulatory signal which directly or indirectly regulates a regulatable, field sensitive transcriptional control element; and

a controller coupled to the gene regulatory signal delivery device, the controller adapted to control the emission of the regulatory signal based on at least a sensed physiological parameter or a command,

wherein the gene regulatory signal delivery device comprises an electromagnetic field generator adapted to emit an electromagnetic field having a predetermined frequency and strength and/or comprises a thermal radiator adapted to emit a thermal energy.

2. The system of claim 1, further comprising a physiological parameter sensor coupled to the controller, wherein the sensor is adapted to sense a physiological parameter indicative of a predetermined condition.

3. The system of claim 2, wherein the predetermined condition is a cardiac condition.

4. The method of claim 3, wherein the cardiac condition is myocardial ischemia, reperfusion or remodeling.

5. The system of claim 4, further comprising a telemetry module coupled to the controller, the telemetry module adapted to receive the command.

6. The system of claim 2, further comprising an event detector to detect the predetermined condition from the sensed physiological parameter, wherein the controller is adapted to control the emission of the regulatory signal in response to a detection of the predetermined condition.

7. The system of claim 6, wherein the sensor comprises a sensor sensing a physiological parameter indicative of ischemia, and the event detector comprises an ischemia detector.

8. The system of claim 2, wherein the sensor comprises an impedance sensor to sense tissue impedance.

9. The system of claim 2, wherein the sensor comprises a metabolic sensor adapted to sense a signal indicative of a cardiac metabolic level.

10. The system of claim 9, wherein the sensor comprises at least one of a pH sensor, an oxygen pressure (PO₂) sensor, a carbon dioxide pressure (PCO₂) sensor, a glucose sensor, a creatine sensor, a C-reactive protein sensor, a creatine kinase sensor, and a creatine kinase-MB sensor.

27. A method to control expression of an open reading frame present in cells of a mammal, comprising:

providing a mammal comprising the system of claim 1 or 11, wherein the mammal comprises cells comprising an expression cassette having the regulatable, field sensitive transcriptional control element operably linked to an open reading frame or comprising an endogenous gene comprising the regulatable, field sensitive transcriptional control element operably linked to an open reading frame; and

directing signal emission in response to the sensed physiological parameter or external command so as to control expression of the open reading frame,

wherein the regulatable, field sensitive transcriptional control element is regulated by thermal energy and/or by electromagnetic energy.

28. The method of claim 27, wherein expression of the open reading frame alters nerve regeneration, bone growth or wound healing.

29. The method of claim 27, wherein the system of claim 1 or 11 is the system of claim 1 wherein the gene regulatory signal delivery device is an external device.

30. The method of claim 27, wherein expression of the open reading frame inhibits ischemia or reperfusion injury.

31. The method of claim 27, wherein the physiological parameter is sensed by an implanted sensor.

32. The method of claim 27, wherein the regulatory signal is delivered in response to a command.

33. The method of claim 32, wherein the command is an external command.

34. The method of claim 27, wherein the system is implanted in or on the heart.

35. The method of claim 27, wherein the system is implanted in or on a blood vessel.

36. The method of claim 27, wherein signal emission controls expression of at least one endogenous gene.

37. The method of claim 27, wherein signal emission controls expression of the regulatable, field sensitive transcriptional control element in the expression cassette.

40. The method of claim 27, wherein the cells comprising the expression cassette are exogenously administered donor cells.

41. The method of claim 27, wherein the expression cassette is introduced to the cells via recombinant virus.

11. A system, comprising;

an implantable medical device system including;

a sensor to sense a physiological parameter indicative of a predetermined condition;

an implant telemetry module to receive an external command;

a gene regulatory signal delivery device that emits a regulatory signal which directly or indirectly regulates a regulatable, field sensitive transcriptional control element; and

an implant controller coupled to the sensor and the implant telemetry module, the implant controller including a gene expression control module adapted to control the emission of the regulatory signal based on at least one of a sensed physiological parameter and the external command; and

an external system including an external telemetry module to transmit the external command to the implant telemetry module,

wherein the gene regulatory signal delivery device comprises an electromagnetic field generator which emits an electromagnetic field having a predetermined frequency and strength and/or comprises a thermal radiator which emits a thermal energy.

12. The system of claim 11, wherein the implantable medical device system further comprises an event detector to detect the predetermined condition from the sensed physiological parameter, and wherein the implant controller is adapted to control the emission of the regulatory signal in response to at least one of the predetermined condition or the external command.

13. The system of claim 11, wherein the sensor comprises a sensor sensing an physiological signal indicative of ischemia, and the event detector comprises an ischemia detector.

14. The system of claim 13, wherein the sensor comprises an impedance sensor to sense tissue impedance.

15. The system of claim 13, wherein the sensor comprises a metabolic sensor adapted to sense a signal indicative of a cardiac metabolic level.

16. The system of claim 13, wherein the implantable medical device system further comprises a pacing circuit coupled to the implant controller, and wherein the implant controller includes a pacing control module adapted to control a delivery of pacing pulses optionally in conjunction with the emission of the regulatory signal.

17. The system of claim 13, wherein the external system comprises:

a presentation device to present the sensed physiological parameter; and

a user input device to receive the external command.

18. A method, comprising:

sensing a physiological parameter indicative of a predetermined condition;

detecting the predetermined condition from the sensed physiological parameter; and

delivering to mammalian cells a regulatory signal which directly or indirectly regulates expression from a regulatable, field sensitive transcriptional control element in the cells in response to at least the detection of the predetermined condition, wherein the regulatable, field sensitive transcriptional control element is operably linked to an open reading frame to form an expression cassette or the regulatable, field sensitive transcriptional control element is operably linked to an open reading frame in an endogenous gene,

wherein thermal energy and/or electromagnetic energy of a predetermined frequency and strength is delivered.

19. The method of claim 18, wherein the expression cassette is in a cell in a mammal.

20. The method of claim 18, wherein sensing the physiological parameter comprises sensing the physiological parameter with an implantable sensor.

21. The method of claim 20, further comprising receiving a command, and delivering the regulatory signal in response to the command.

22. The method of claim 21, wherein receiving the command comprises receiving an external command transmitted to an implantable device from an external system.

23. The method of claim 22, further comprising:

transmitting one or more of the sensed physiological parameters and a detection of the predetermined condition to an external system; and

presenting the one or more of the sensed physiological parameters and a detection of the predetermined condition through the external system.

24. The method of claim 23, wherein the sensing the physiological parameter comprises sensing a physiological parameter indicative of ischemia, and detecting the predetermined condition comprises detecting an ischemia.

25. The method of claim 18, further comprising delivering pacing pulses in conjunction with delivering the regulatory signal.

26. The method of claim 18, further comprising delivering cardioversion/defibrillation shocks in conjunction with delivering the regulatory signal.

38. The method of claim 18 or 27, wherein the regulatable, field sensitive transcriptional control element comprises a heat shock protein promoter.

39. The method of claim 18 or 27, wherein the open reading frame encodes a growth factor, Akt, hypoxia inducible factor, or a pacemaker ion channel.